Jon Congleton - Net Worth and Insider Trading
Jon Congleton Net Worth
The estimated net worth of Jon Congleton is at least $12 Million dollars as of 2024-11-29. Jon Congleton is the CEO of Mineralys Therapeutics Inc and owns about 895,941 shares of Mineralys Therapeutics Inc (MLYS) stock worth over $12 Million. Jon Congleton is also the President and CEO of Alpine Immune Sciences Inc and owns about 5,000 shares of Alpine Immune Sciences Inc (ALPN) stock worth over $324,850. Details can be seen in Jon Congleton's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jon Congleton has not made any transactions after 2024-10-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Jon Congleton
Jon Congleton Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jon Congleton owns 2 companies in total, including Alpine Immune Sciences Inc (ALPN) , and Mineralys Therapeutics Inc (MLYS) .
Click here to see the complete history of Jon Congleton’s form 4 insider trades.
Insider Ownership Summary of Jon Congleton
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ALPN | Alpine Immune Sciences Inc | 2016-06-16 | director & President & CEO |
| MLYS | Mineralys Therapeutics Inc | 2024-10-11 | director & Chief Executive Officer |
Jon Congleton Latest Holdings Summary
Jon Congleton currently owns a total of 2 stocks. Among these stocks, Jon Congleton owns 895,941 shares of Mineralys Therapeutics Inc (MLYS) as of October 11, 2024, with a value of $12 Million and a weighting of 97.31%. Jon Congleton also owns 5,000 shares of Alpine Immune Sciences Inc (ALPN) as of June 16, 2016, with a value of $324,850 and a weighting of 2.69%.
Latest Holdings of Jon Congleton
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| MLYS | Mineralys Therapeutics Inc | 2024-10-11 | 895,941 | 13.11 | 11,745,787 |
| ALPN | Alpine Immune Sciences Inc | 2016-06-16 | 5,000 | 64.97 | 324,850 |
Holding Weightings of Jon Congleton
Jon Congleton Form 4 Trading Tracker
According to the SEC Form 4 filings, Jon Congleton has made a total of 8 transactions in Mineralys Therapeutics Inc (MLYS) over the past 5 years, including 4 buys and 4 sells. The most-recent trade in Mineralys Therapeutics Inc is the sale of 15,271 shares on October 11, 2024, which brought Jon Congleton around $206,464.
According to the SEC Form 4 filings, Jon Congleton has made a total of 0 transactions in Alpine Immune Sciences Inc (ALPN) over the past 5 years. The most-recent trade in Alpine Immune Sciences Inc is the acquisition of 1,250 shares on June 16, 2016, which cost Jon Congleton around $19,350.
Insider Trading History of Jon Congleton
- 1
Jon Congleton Trading Performance
GuruFocus tracks the stock performance after each of Jon Congleton's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jon Congleton is 9.76%. GuruFocus also compares Jon Congleton's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jon Congleton within 3 months outperforms 3 times out of 8 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Jon Congleton's insider trading performs compared to the benchmark.
Performance of Jon Congleton
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 3.03 | | | | | |
| Relative Return to S&P 500(%) | 2.09 | | | | | |
Jon Congleton Ownership Network
Jon Congleton Owned Company Details
What does Alpine Immune Sciences Inc do?
Who are the key executives at Alpine Immune Sciences Inc?
Jon Congleton is the director & President & CEO of Alpine Immune Sciences Inc. Other key executives at Alpine Immune Sciences Inc include Senior VP and CFO James Paul Rickey , director & Executive Chairman and CEO Mitchell Gold , and director & 10 percent owner Xiangmin Cui .
Alpine Immune Sciences Inc (ALPN) Insider Trades Summary
Over the past 18 months, Jon Congleton made no insider transaction in Alpine Immune Sciences Inc (ALPN). Other recent insider transactions involving Alpine Immune Sciences Inc (ALPN) include a net sale of 281,514 shares made by James Paul Rickey , a net sale of 213,302 shares made by Mitchell Gold , and a net sale of 1,546,347 shares made by Orbimed Advisors Llc .
In summary, during the past 3 months, insiders sold 0 shares of Alpine Immune Sciences Inc (ALPN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 3,587,529 shares of Alpine Immune Sciences Inc (ALPN) were sold and 750,000 shares were bought by its insiders, resulting in a net sale of 2,837,529 shares.
Alpine Immune Sciences Inc (ALPN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Alpine Immune Sciences Inc Insider Transactions
Jon Congleton Mailing Address
Above is the net worth, insider trading, and ownership report for Jon Congleton. You might contact Jon Congleton via mailing address: 3122 Sterling Circle, Suite 200, Boulder Co 80301.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
